DPH Share Price

Open 2022.00 Change Price %
High 2029.00 1 Day -16.00 -0.79
Low 2000.00 1 Week -43.00 -2.10
Close 2005.00 1 Month 156.00 8.44
Volume 87779 1 Year 641.00 46.99
52 Week High 2149.00
52 Week Low 1225.00
DPH Important Levels
Resistance 2 2031.88
Resistance 1 2020.81
Pivot 2011.33
Support 1 1989.20
Support 2 1978.12
LON UK Most Active Stocks
CWC 74.60 0.27%
CWC 74.60 0.27%
CWC 74.60 0.27%
INC 0.04 -20.00%
LLOY 65.71 -0.44%
IRG 0.40 0.00%
IRG 0.40 0.00%
IRG 0.40 0.00%
IRG 0.40 0.00%
IRG 0.40 0.00%
More..
LON UK Top Gainers Stocks
AKT 28.50 5177.78%
HHR 58.00 900.00%
MLD 10.00 700.00%
MES 0.28 75.00%
MES 0.28 75.00%
MES 0.28 75.00%
PFLM 5.75 64.29%
BAC 22.54 61.00%
BAC 22.54 61.00%
BAC 22.54 61.00%
More..
LON UK Top Losers Stocks
ENDV 0.02 -99.85%
KEA 0.10 -91.30%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
ACU 0.05 -87.50%
DCP 0.50 -75.61%
PCI 3.50 -53.27%
PCI 3.50 -53.27%
BHR 0.02 -33.33%
NBR 0.25 -24.24%
More..

Dechra Pharmaceuticals PLC (LON: DPH)

DPH Technical Analysis 4
As on 20th Sep 2017 DPH Share Price closed @ 2005.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 1623.28 & Buy for SHORT-TERM with Stoploss of 1840.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
DPH Target for September
1st Target up-side 2018.19
2nd Target up-side 2091.91
3rd Target up-side 2165.64
1st Target down-side 1807.82
2nd Target down-side 1734.09
3rd Target down-side 1660.36
DPH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dechra.com
DPH Address
DPH
24 Cheshire Avenue
Cheshire Business Park
Northwich, CW9 7UA
United Kingdom
Phone: 44 1606 814 730
Fax: 44 1606 814 731
DPH Latest News
Interactive Technical Analysis Chart Dechra Pharmaceuticals PLC ( DPH LON UK )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dechra Pharmaceuticals PLC
DPH Business Profile
Dechra Pharmaceuticals PLC is engaged in the development, manufacture, distribution, sale, and marketing of veterinary pharmaceuticals worldwide. It markets and sells licensed branded pharmaceuticals and specialist pet foods to the veterinary professionals in Europe, as well as manufactures products for third party customers. The company also markets and sells a range of endocrine, ophthalmic, dermatological, and equine products in North America. In addition, it develops and licenses its branded veterinary product portfolio of novel and generic pharmaceuticals, and specialist pet diets. The company distributes its products through a mixture of its own direct sales, wholesalers, and national distributor channels. Dechra Pharmaceuticals PLC is headquartered in Northwich, the United Kingdom.